DAWN Financials
Day One Biopharmaceuticals Inc - Financial statements & key metrics
Stock Price
$0.00
Market Cap
$656.83M
Income Statement Highlights
Most Recent Quarter: 2024-12-31
Revenue
$131.16M
Gross Profit
-
Operating Income
-
Net Income
$-95.50M
EPS (Diluted)
$-1.02
Balance Sheet Highlights
Total Assets
$582.79M
Total Liabilities
$80.04M
Shareholders Equity
-
Cash & Equivalents
$124.97M
Total Debt
-
Cash Flow Highlights
Operating Cash Flow
$-78.11M
CapEx
-
Free Cash Flow
-
Profitability Metrics
View Complete Financial Statements
Full income statements, balance sheets, and cash flows for multiple periods
Open Full FinancialsFrequently Asked Questions
What is DAWN revenue?
DAWN's most recent quarterly revenue was $131.16M. Annual revenue can be calculated by summing the four most recent quarters.
Is DAWN profitable?
DAWN reported a loss of $95.50M in the most recent quarter.
What is DAWN market cap?
DAWN has a market capitalization of $656.83M, making it a small-cap stock.
Does DAWN have debt?
View DAWN's balance sheet for debt information.
What is DAWN cash flow?
Cash flow data is available in the full financial statements.